NantOmics
Culver City · Founded 2012
About NantOmics
NantOmics develops cloud-based molecular profiling tools that help guide cancer patients. It is a molecular diagnostics company, develops molecular profiling solutions that identify personalized treatment options for cancer patients and their providers at the point of care. It offers GPS Cancer test that provides a molecular profile of patient’s cancer to inform personalized treatment strategies to oncologists and OncoPlexDx Targeted Proteomic panel that provides quantitative protein biomarker information for multiple clinically relevant proteins yielding insights into the biology driving the growth of the patient’s cancer. Patrick Soon-Shiong founded NantOmics in 2012, with its headquarters in Culver City, California. NantOmics operates as a subsidiary of NantWorks.
Company Facts
- Founded: 2012
- Legal name: NantOmics, LLC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $250.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2015)
- Website: nantomics.com
- Phone: 310-883-1300
Social Profiles
Canonical: https://fsome.com/organization/nantomics-8354100 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.